Navigation Links
Hearing Loss May Hasten Mental Decline
Date:1/22/2013

By Amy Norton
HealthDay Reporter

MONDAY, Jan. 21 (HealthDay News) -- Seniors who have trouble hearing may see their thinking skills slip away faster than others do, new research suggests.

The study of older U.S. adults found that those with hearing problems were 24 percent more likely to develop mental impairment over six years.

The Johns Hopkins researchers don't know for sure whether hearing loss directly causes mental decline in some cases -- or whether using hearing aids might help. But they are planning to study that possibility.

"At this point, the particular neural mechanisms -- that is, the 'why' and 'how' -- that link hearing loss to dementia are unclear," said Daniel Polley, of the Massachusetts Eye and Ear Infirmary and Harvard Medical School in Boston.

What is clear is that older adults should take hearing problems seriously, noted Polley, who was not involved with the study.

"If there is a takeaway to this, it would be to encourage folks to have their hearing tested by a health professional," Polley said.

The findings, which appear in the Jan. 21 issue of JAMA Internal Medicine, are based on 1,984 adults in their 70s and 80s who showed no signs of impaired memory or thinking at the study's start. But the majority -- 1,162 in all -- did show some hearing loss.

Over the next six years, 609 men and women developed new signs of mental impairment -- based on a standard test of memory, concentration and language skills. And that risk was 24 percent higher among people who had hearing problems.

The researchers estimate that it would take a hearing-impaired older adult just under eight years, on average, to develop mental impairment, versus 11 years for their peers with normal hearing.

None of that proves cause-and-effect. However, the researchers did account for a number of factors that might have explained the link, such as people's education levels, smoking
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Grant awarded to help improve problem-solving skills for deaf and hard-of-hearing students
2. Cone beam CT proves better for visualizing some causes of hearing loss at half the radiation dose
3. ASTRO chairman to testify at CARE Act hearing
4. C-Section Babies May Be More Likely to Fail First Hearing Test
5. Children exposed to HIV in the womb at increased risk for hearing loss
6. HIV Exposure Before Birth May Raise Kids Risk of Hearing Loss
7. New screening test to help people with hearing loss in China
8. Suffering of Thousands Prompts FDA Hearing about Hip Implants
9. Not Enough Data to Advise Routine Hearing Screens for Older People: Experts
10. Rewired visual input to sound-processing part of the brain leads to compromised hearing
11. Report: Strategies to prevent noise-induced hearing loss, tinnitus in soldiers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hearing Loss May Hasten Mental Decline
(Date:7/22/2014)... of Hematology (ASH) will honor Michael DeBaun, MD, MPH, ... Hebbel, MD, of the University of Minnesota Medical School ... their significant research advances in the area of sickle ... the late Ernest Beutler, MD, a past president of ... a two-part lectureship that recognizes major translational advances related ...
(Date:7/22/2014)... American Society of Hematology (ASH) will present the Society,s ... Lifetime Achievement in Hematology, to Kanti R. Rai, MD, ... of Medicine for his 50-year career combining landmark clinical ... exceptional patient care. , The Wallace H. Coulter ... an individual who has been a vital contributor to ...
(Date:7/22/2014)... on cholesterol treatment and cardiovascular risk assessment state that ... from atherosclerotic cardiovascular disease or of having a heart ... risk profile (based on age, smoking history, and cholesterol ... for when and how aggressively to treat high cholesterol ... Men,s Health , a peer-reviewed publication from Mary Ann ...
(Date:7/22/2014)... 22, 2014 The Entertainment Industries Council, ... resources, educational tools and recognition activities for thousands of ... prevention, treatment and recovery. On July 24, 2014, at ... some of these resources with a special mention of ... and treatment website at the end of the show. ...
(Date:7/22/2014)... --,High school lacrosse players are facing an increasing number ... new study finds. Although the most common injuries ... concussions, researchers report. They note a better understanding of ... ways to protect student athletes. "Concern over concussions ... to learn more about these injuries," said study co-author ...
Breaking Medicine News(10 mins):Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Injuries on the Increase in High School Lacrosse, Study Shows 2Health News:Injuries on the Increase in High School Lacrosse, Study Shows 3
... DALLAS, Nov. 21 Susan G. Komen for ... for breast cancer research and,community-based outreach programs, is ... students who lost a,parent to breast cancer., ... Scholarship Award helps students cover the costs of,tuition, ...
... Nov. 21 Inverness Medical,Innovations, Inc. (Amex: IMA ... offering on Tuesday. The Company sold a total,of 13,634,302 ... of $61.49,per share. The total number of shares sold ... upon their exercise of their,over-allotment option in full. Certain ...
... and often deadly among older American women, doctors too ... a new report by a team of vascular surgeons ... Medical College campuses of NewYork-Presbyterian Hospital. , Much of ... cardiovascular research has focused almost exclusively on males, so ...
... Genomic Health,Inc. (Nasdaq: GHDX ) today announced ... Executive Officer, will present at the Piper,Jaffray Health ... 28, 2007 at 1:00,p.m. Eastern Time., To ... the,presentation, visit the Investor Relations section of Genomic ...
... Ore., Nov. 21 ,Danaher Corporation (NYSE: DHR ) ... the expiration, as of 11:59 PM, New York City ... in the tender offer,made by Raven Acquisition Corp., Danaher,s ... of Tektronix, Inc. common,stock. The initial tender offer period ...
... plans that give best value for money, study finds , ... aren,t implementing strategies and programs to improve the quality and ... in the Nov. 21 issue of the Journal of ... Health researchers surveyed 609 executives of the largest employers ...
Cached Medicine News:Health News:Susan G. Komen for the Cure Provides Scholarships for Students Who Lost a Parent to Breast Cancer 2Health News:Inverness Medical Innovations Announces Closing of Public Offering 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 3Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 4Health News:Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 2Health News:Danaher Closes Subsequent Offering Period for Tektronix; Acquires Over 90% of TEK Shares 2Health News:Most U.S. Companies Do Little to Boost Worker Health Benefits 2
(Date:7/22/2014)... , July 22, 2014  NeuroSigma, Inc. (NeuroSigma), ... focused on commercialization of its non-invasive Monarch ... and neuropsychiatric disorders, today announced that enrollment has begun ... nerve stimulation (eTNS) as adjunctive therapy for the treatment ... being conducted at the Olive View-UCLA Medical Center in ...
(Date:7/22/2014)... York , July 22, 2014 ... Partnerschaft für umfassenden Schutz von Pharmazeuten ... Österreich    Equashield ( ... Transfersystemen (Closed System Transfer Devices, CSTDs) für gefährliche ... einen Vertriebshändler und Hersteller von medizinischen ...
(Date:7/21/2014)... McCord Research, Inc. was recently granted ... This patent describes a method for accelerating wound ... inventor, Dr. McCord, this method includes administering or ... composition of an effective amount of hydroxytyrosol and ... such that the administration of the combination reduces ...
Breaking Medicine Technology:Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 2Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 3Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 5Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2US Patent Office Grants McCord Research Endothelial Cell Treatment Patent 2
... well-tolerated with signs of durable,disease control in advanced ... /PRNewswire-FirstCall/ -- IDM,Pharma, Inc. today presented preliminary results ... trial (DC-MEL-202). The,results showed that UVIDEM was well ... response in patients with,progressive metastatic melanoma. , The ...
... trial presented at ENDO 2007 , ,- Regulatory approvals ... recruitment in Europe , ,MONTREAL, QUEBEC -- (MARKET WIRE) ... that 26-week data from,its first Phase 3 study testing ... ENDO, the 89th,annual meeting of the Endocrine Society. The ...
Cached Medicine Technology:IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5Theratechnologies: TH9507 Phase 3 Clinical Update 2Theratechnologies: TH9507 Phase 3 Clinical Update 3
... practical, comfortable chair for examination ... height is adjustable from 540 ... use of an independent foot ... through 360 and incorporates a ...
... Halogen HPX Streak Retinoscope ... handle and provides 40% ... conventional scopes and maintains ... which greatly enhances illumination ...
Sandown chair, with hydraulic lift, sliding headrest and armrests with glides. Black vinyl....
3.5v Halogen HPX Spot Retinoscope provides 40% more light output than conventional scopes and maintains a consistent output level which greatly enhances illumination and produces the sharpest retina...
Medicine Products: